Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9522129 Pharmaceutical Combination

Patent 9522129 was granted and assigned to Velicept Therapeutics on December, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 2 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 2 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12102638 Use of vibegron to treat overactive bladder
0
Edits on 5 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 5 Dec, 2023
Edits made to:
Article (+387 characters)
Article

Patent abstract

Pharmaceutical combinations comprising a beta-3 adrenergic receptor agonist and a muscarinic receptor antagonist, and methods for their use are disclosed. Methods of using the pharmaceutical combinations for the treatment of one or more symptoms associated with overactive bladder, for example, frequency of urgency, nocturia, and urinary incontinence, are also disclosed.

Edits on 29 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 29 Sep, 2023
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Eliot Ohlstein0
Stephen Caltabiano0
Stewart McCallum0
Edits on 15 Jul, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 15 Jul, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 09522129 Pharmaceutical Combination US Patent 9522129 Pharmaceutical Combination

Infobox
Patent Number
095221290
Patent Number
95221290
Edits on 23 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 23 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=095221290
Edits on 5 Oct, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 5 Oct, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
‌
Velicept Therapeutics
0
Current Assignee
‌
Velicept Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
095221290
Date of Patent
December 20, 2016
0
Patent Application Number
137625630
Date Filed
February 8, 2013
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=095221290
Patent Primary Examiner
‌
Scarlett Goon
0
Edits on 6 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 6 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=09522129
Edits on 9 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 9 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 09522129 Pharmaceutical Combination

Infobox
Is a
Patent
Patent
Patent applicant
‌
Velicept Therapeutics
Current assignee
‌
Velicept Therapeutics
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
09522129
Date of patent
December 20, 2016
Patent application number
13762563
Date Filed
February 8, 2013
Patent primary examiner
‌
Scarlett Goon

Find more entities like US Patent 9522129 Pharmaceutical Combination

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo